Your browser doesn't support javascript.
loading
The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation.
Lee, Chung-Ying; Wu, Mei-Yi; Chan, Hsiu-Chen; Chen, Tzu-Ting; Hsu, Le-Yin; Wu, Mai-Szu; Cherng, Yih-Giun.
Affiliation
  • Lee CY; Division of Gastroenterology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Wu MY; Division of Gastroenterology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Chan HC; Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Chen TT; Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Hsu LY; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Wu MS; TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
  • Cherng YG; Department of Pharmacy, Shuang Ho Hospital, New Taipei City, Taiwan.
Transpl Int ; 35: 10023, 2022.
Article in En | MEDLINE | ID: mdl-35185375
ABSTRACT
This retrospective study aimed to investigate the effect of diabetes mellitus (DM) on the risks of end-stage kidney disease (ESKD) and post-liver transplantation (post-LT) mortality. Using data from the National Health Insurance Research Database, Taiwan, 3,489 patients who received a LT between 1 January 2005, and 31 December 2015, were enrolled in this study and divided into the pre-existing DM, post-LT DM (PLTDM), and without DM groups. All subjects were followed up from 1 year after LT to the index date for ESKD, and the occurrence of death, or until 31 December 2016. Of the 3,489 patients with LT, 1,016 had pre-existing DM, 215 had PLTDM, and 2,258 had no DM pre- or post-LT. The adjusted HRs of ESKD were 1.77 (95% Confidence Interval [CI], .78-3.99) and 2.61 (95% CI, 1.63-4.18) for PLTDM group and pre-existing DM group compared to without DM group, respectively. For the risk of death, the adjusted HRs were 1.05 (95% CI, .72-1.55) and 1.28 (95% CI, 1.04-1.59) for PLTDM group and pre-existing DM group compared to those without DM group, respectively. The sensitivity analysis for the risk of ESKD and death also revealed the consistent result. Pre-existing DM has significant increase the risk of post-LT ESKD and mortality. The role of PLTDM should be explored to explain postoperative morbidity and mortality.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Diabetes Mellitus / Kidney Failure, Chronic Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Transpl Int Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: Taiwan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Diabetes Mellitus / Kidney Failure, Chronic Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Transpl Int Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: Taiwan